RT Journal Article
SR Electronic
T1 713 Nanrilkefusp alfa, a high-affinity IL-15Rβγ agonist, promotes an innate and adaptive anti-tumour inflammatory environment as single agent or combined with anti-PD-1 in patients with advanced cancers
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A808
OP A808
DO 10.1136/jitc-2023-SITC2023.0713
VO 11
IS Suppl 1
A1 Danek, Petr
A1 Simonova, Ekaterina
A1 Podzimkova, Nada
A1 Bechard, David
A1 Sachse, Richard
A1 Kiemle-Kallee, Joachim
A1 Moebius, Ulrich
A1 Spisek, Radek
A1 Adkins, Irena
A1 Steegmaier, Martin
A1 Jelinkova, Lenka Palova
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A808.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.